Pressure increases to finance MS drugs

By Lyn Whitfield1998-06-18T00:00:00

Health authorities could be under pressure to fund Betaferon treatment for thousands more patients - at a cost of millions of pounds - by the end of the year.

You need to be a subscriber to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All HSJ news by sector, topic & region
Breaking News announcements
App for mobile and offline reading
Comment and Daily Insights newsletters
Regional roundup newsletters
Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant
10 expert briefings every fortnight (Premium only)

to HSJ

Already a subscriber? Sign into your account here